144 related articles for article (PubMed ID: 2572951)
1. Abnormal signal transduction: a hypothetical model for bipolar affective disorder.
Lachman HM; Papolos DF
Life Sci; 1989; 45(16):1413-26. PubMed ID: 2572951
[TBL] [Abstract][Full Text] [Related]
2. Signal transduction pathways. Molecular targets for lithium's actions.
Manji HK; Potter WZ; Lenox RH
Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
Ikonomov OC; Manji HK
Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action.
Divish MM; Sheftel G; Boyle A; Kalasapudi VD; Papolos DF; Lachman HM
J Neurosci Res; 1991 Jan; 28(1):40-8. PubMed ID: 1674966
[TBL] [Abstract][Full Text] [Related]
5. Neurobiology of lithium: an update.
Lenox RH; McNamara RK; Papke RL; Manji HK
J Clin Psychiatry; 1998; 59 Suppl 6():37-47. PubMed ID: 9674936
[TBL] [Abstract][Full Text] [Related]
6. Lithium therapy for mania and depression.
Murray JB
J Gen Psychol; 1985 Jan; 112(1):5-33. PubMed ID: 2860201
[TBL] [Abstract][Full Text] [Related]
7. The calcium second messenger system in bipolar disorders: data supporting new research directions.
Dubovsky SL; Murphy J; Christiano J; Lee C
J Neuropsychiatry Clin Neurosci; 1992; 4(1):3-14. PubMed ID: 1320969
[TBL] [Abstract][Full Text] [Related]
8. A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder.
McEachin RC; Chen H; Sartor MA; Saccone SF; Keller BJ; Prossin AR; Cavalcoli JD; McInnis MG
BMC Syst Biol; 2010 Nov; 4():158. PubMed ID: 21092101
[TBL] [Abstract][Full Text] [Related]
9. Is the Na(+)-K(+)-ATPase the link between phosphoinositide metabolism and bipolar disorder?
el-Mallakh RS; Li R
J Neuropsychiatry Clin Neurosci; 1993; 5(4):361-8. PubMed ID: 8286932
[TBL] [Abstract][Full Text] [Related]
10. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
Machado-Vieira R
J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
[TBL] [Abstract][Full Text] [Related]
11. Exploring lithium's transcriptional mechanisms of action in bipolar disorder: a multi-step study.
Akkouh IA; Skrede S; Holmgren A; Ersland KM; Hansson L; Bahrami S; Andreassen OA; Steen VM; Djurovic S; Hughes T
Neuropsychopharmacology; 2020 May; 45(6):947-955. PubMed ID: 31652432
[TBL] [Abstract][Full Text] [Related]
12. Potential mechanisms of action of lithium in bipolar disorder. Current understanding.
Malhi GS; Tanious M; Das P; Coulston CM; Berk M
CNS Drugs; 2013 Feb; 27(2):135-53. PubMed ID: 23371914
[TBL] [Abstract][Full Text] [Related]
13. The lithium ion: a foundation for psychopharmacological specificity.
Soares JC; Gershon S
Neuropsychopharmacology; 1998 Sep; 19(3):167-82. PubMed ID: 9653704
[TBL] [Abstract][Full Text] [Related]
14. A molecular model for bipolar affective disorder.
Lachman HM; Papolos DF
Med Hypotheses; 1995 Sep; 45(3):255-64. PubMed ID: 8569548
[TBL] [Abstract][Full Text] [Related]
15. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
Won E; Kim YK
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232923
[TBL] [Abstract][Full Text] [Related]
16. Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis.
Tobe BTD; Crain AM; Winquist AM; Calabrese B; Makihara H; Zhao WN; Lalonde J; Nakamura H; Konopaske G; Sidor M; Pernia CD; Yamashita N; Wada M; Inoue Y; Nakamura F; Sheridan SD; Logan RW; Brandel M; Wu D; Hunsberger J; Dorsett L; Duerr C; Basa RCB; McCarthy MJ; Udeshi ND; Mertins P; Carr SA; Rouleau GA; Mastrangelo L; Li J; Gutierrez GJ; Brill LM; Venizelos N; Chen G; Nye JS; Manji H; Price JH; McClung CA; Akiskal HS; Alda M; Chuang DM; Coyle JT; Liu Y; Teng YD; Ohshima T; Mikoshiba K; Sidman RL; Halpain S; Haggarty SJ; Goshima Y; Snyder EY
Proc Natl Acad Sci U S A; 2017 May; 114(22):E4462-E4471. PubMed ID: 28500272
[TBL] [Abstract][Full Text] [Related]
17. Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness.
Lenox RH; Watson DG
Clin Chem; 1994 Feb; 40(2):309-14. PubMed ID: 8313612
[TBL] [Abstract][Full Text] [Related]
18. Molecular effects of lithium.
Quiroz JA; Gould TD; Manji HK
Mol Interv; 2004 Oct; 4(5):259-72. PubMed ID: 15471909
[TBL] [Abstract][Full Text] [Related]
19. Neurobiological Considerations of the mode of action of lithium carbonate in the treatment of affective disorders?
Bunney WE; Murphy DL
Pharmakopsychiatr Neuropsychopharmakol; 1976 May; 9(3):142-7. PubMed ID: 185630
[TBL] [Abstract][Full Text] [Related]
20. Lithium therapy in the treatment of manic-depressive illness. Present status and future perspectives. A critical review.
Emilien G; Maloteaux JM; Seghers A; Charles G
Arch Int Pharmacodyn Ther; 1995; 330(3):251-78. PubMed ID: 8836446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
